GSK (GSK) and Genmab Receive FDA Approval for Wider Use of Arzerra
Tweet Send to a Friend
GlaxoSmithKline plc (NYSE: GSK) and Genmab A/S (Copenhagen: GEN) announced today that the U.S. Food and Drug Administration (FDA) has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
